
open access
메뉴
E-ISSN : 2671-6771
ZNF462 haploinsufficiency is the recognized cause of Weiss-Kruszka syndrome, a neurodevelopmental disorder characterized by global developmental delay, craniofacial anomalies, hypotonia, and midline brain defects. So far, ZNF462 has not been implicated in reproductive endocrinology or congenital hypogonadotropic hypogonadism. However, new clinical evidence challenges this view. A Finnish boy reported by Iivonen et al. carried a 9q31.2 microdeletion encompassing ZNF462 and displayed both Weiss-Kruszka syndrome and Kallmann syndrome. Because ZNF462 had not been associated with reproductive phenotypes at the time, the authors proposed that an unknown Kallmann syndrome gene within the deleted interval must explain the endocrine findings. Subsequently, Park et al. described a Korean boy with a truncating ZNF462 variant who exhibited Weiss-Kruszka syndrome together with an empty sella, growth hormone deficiency, and markedly delayed puberty. In this case, isolated ZNF462 loss-of-function variant-without a multigene deletion-should account for the endocrine abnormalities. More recently, Zhou et al. reported a prepubertal Chinese boy harboring a heterozygous truncating ZNF462 variant who presented with bilateral cryptorchidism and complete growth hormone deficiency, further supporting a role for ZNF462 haploinsufficiency in hypothalamic-pituitarygonadal axis dysfunction. Together, these cases provide converging evidence that ZNF462 disruption can affect development and function of the hypothalamic-pituitary-gonadal axis. This mini-review synthesizes current data, explores biological plausibility based on ZNF462 molecular interactions, and discusses how neurodevelopmental disorders and delayed puberty frequently cooccur due to shared developmental pathways. We propose that ZNF462 should now be considered a strong candidate gene for Kallmann syndrome and highlight the need for systematic reanalysis of genomic datasets to define its role more precisely.